HF
STAB

HRT Financial’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

HRT Financial’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,494
Closed -$1K – 3604
2022
Q4 		$1K Buy
+24,494
New +$3.11K ﹤0.01% 2401
2022
Q2 		– Sell
-22,539
Closed -$7K – 4025
2022
Q1 		$7K Buy
+22,539
New +$24.1K ﹤0.01% 2938

Other funds holding STAB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

HRT Financial's STAB Position: Q1 2023 in Review

HRT Financial sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 24,494 shares — an estimated $1K sold.

HRT Financial first reported a position in STAB in Q1 2022 and held it in 2 quarters. The position peaked at $7K in Q1 2022. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

  • HRT Financial reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 24,494 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $1K.
  • HRT Financial first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • HRT Financial's Statera Biopharma, Inc. Common Stock position peaked at $7K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.